Latest Articles

Publication Date
Social Media Health Information Formats and Endometriosis Treatment-Seeking Intentions: A Randomized Controlled Trial.

BackgroundDespite many women learning about endometriosis on social media, posts about the condition often fail to reflect current evidence. With the content and credibility of online health messages being found …

Published: April 13, 2026, midnight
Reply of the authors: Trial emulation and clinical trials.

Published: April 11, 2026, midnight
Non-Mineral Antioxidant Supplementation in Endometriosis: Biological Rationale, Clinical Evidence, and Therapeutic Implications-A Narrative Review.

Background/Objectives: Oxidative stress plays an important role in the pathophysiology of endometriosis, contributing to inflammation, immune dysregulation, and lesion progression. This has led to growing interest in antioxidant-based strategies as …

Published: April 9, 2026, midnight
Efficacy of probiotic supplementation in reducing primary dysmenorrhea: a double-blinded randomized controlled trial.

Primary dysmenorrhea is painful menstruation in the absence of pelvic pathology, whereas secondary dysmenorrhea is menstrual pain attributable to an underlying pelvic disease (e.g., endometriosis). Nonsteroidal anti-inflammatory drugs (NSAIDs) are …

Published: March 17, 2026, midnight
Endometriosis Pain Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma, Abbvie - Barchart.com

Endometriosis Pain Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma, Abbvie Barchart.com

Published: March 4, 2026, 1:30 p.m.
Dietary Fiber in Endometriosis: Mechanisms, Evidence, and Potential Clinical Benefits-Up-to-Date Review.

Background: Endometriosis is a chronic, estrogen-dependent inflammatory disorder. It is associated with hormonal dysregulation, pelvic pain, and a reduced quality of life. Dietary factors may influence disease development and symptom …

Published: Feb. 21, 2026, midnight
Sensei finds Faeth | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Sensei finds Faeth | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Published: Feb. 19, 2026, 3:47 p.m.
Nanotechnology for reproductive healthcare: a comprehensive review.

The advancement of nanotechnology has revolutionized reproductive healthcare worldwide. It has enabled the treatment of various conditions, such as infertility, endometriosis, ectopic pregnancies, erectile dysfunction, sexually transmitted infections (STIs), and …

Published: Feb. 9, 2026, midnight
Therapeutic potential of epigallocatechin gallate in gynecologic cancer, endometriosis, polycystic ovary syndrome: a mechanistic and translational perspective.

Tea, among the most widely consumed beverages worldwide, is rich in polyphenolic compounds known as catechins, particularly epigallocatechin gallate (EGCG). This review aims to synthesize recent findings and ongoing controversies …

Published: Jan. 13, 2026, midnight
No checkpoint glory for Acrivon | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

No checkpoint glory for Acrivon | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Published: Jan. 12, 2026, 1:11 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!